Ever since the first description of circulating, non-encapsulated DNA in the bloodstream, the detection in body fluids of DNA that originates from malignant tumors has attracted considerable interest for diagnostic and therapeutic purposes. Over the years, some of the challenges surrounding circulating DNA have revolved around developing methods to allow for its sensitive detection, interrogating its composition, and translating research findings into clinical applications.

Source : Genetic Engineering News

>> Read full article